SCM
SRRA

Silverarc Capital Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Silverarc Capital Management’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-443,381
Closed -$14.2K – 99
2022
Q1 		$14.2K Buy
443,381
+251,336
+131% +$7.21M 6.73% 4
2021
Q4 		$4.17M Buy
192,045
+28,559
+17% +$629K 1.87% 18
2021
Q3 		$3.58M Buy
163,486
+24,181
+17% +$484K 2.08% 17
2021
Q2 		$2.71K Buy
139,305
+4,624
+3% +$84K 1.32% 29
2021
Q1 		$2.32M Sell
134,681
-319
-0.2% -$5.05K 1.3% 31
2020
Q4 		$2.16M Buy
+135,000
New +$1.87M 1.32% 32

Other funds holding SRRA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.09B AUM 72.99% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return